Molina Healthcare, Inc

MOH Healthcare Healthcare Plans

Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

209.87 5.51 +2.70%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
55.0×
Dividend yield
—
F-score
4/9
Altman Z
4.28
Beneish M
−1.99
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
20.27 14.25 19.78 23.54 28.27 18.94 11.83 11.00 0.00 58.10
Piotroski F-Score
4 5 8 8 6 5 4 5 3 4
Altman Z-Score
4.28 4.60 4.53 4.77 4.27 4.06 4.88 4.50 2.82 3.21
P/S ratio
0.20 0.41 0.63 0.58 0.66 0.65 0.50 0.38 0.22 0.17
P/FCF ratio
0.00 30.71 13.59 27.03 9.00 6.88 22.39 0.00 6.08 5.97
Altman Z″-Score (non-manufacturers)
3.60 4.06 3.90 3.43 3.11 3.70 4.92 3.87 1.38 2.18
Beneish M-Score
(1.99) (2.15) (2.41) (2.41) (2.59) (2.55) (2.06) (1.48) (3.45) (2.29)
P/Operating CF
(30.75) (74.58) (31.07) (86.95) 30.80 9.66 234.44 (57.64) (28.55) 74.22
P/B ratio
2.25 3.72 5.09 6.22 6.99 5.99 4.31 4.30 3.27 1.80
Price to Tangible BV
4.89 6.53 7.75 11.71 13.34 10.86 4.72 4.87 4.04 3.34
EV/Sales
0.11 0.27 0.43 0.42 0.47 0.46 0.33 0.21 0.03 0.00
EV/EBITDA
5.00 5.74 8.45 9.89 11.44 7.63 4.88 3.21 0.00 0.08
EV/Operating CF
(9.13) 16.87 8.87 17.26 6.21 4.69 12.74 (12.87) 0.82 0.05
EV/FCF
(7.68) 19.97 9.34 19.57 6.45 4.88 14.66 (11.75) 0.92 0.07
Quick Ratio
1.60 1.56 1.50 1.43 1.39 1.55 1.78 1.37 1.21 1.22
Current Ratio
1.69 1.62 1.54 1.47 1.43 1.59 1.83 1.52 1.35 1.31
Net Debt/EBITDA
(4.41) (3.10) (3.85) (3.79) (4.56) (3.15) (2.59) (2.42) 10.75 (6.01)
Debt/Assets
25.38% 19.95% 16.02% 19.42% 19.59% 24.67% 21.63% 20.38% 25.61% 22.08%
Debt/Equity
0.97 0.69 0.57 0.81 0.91 1.12 0.75 0.89 1.62 1.00
Asset Turnover
2.91 2.66 2.50 2.61 2.55 2.38 2.41 2.42 2.50 2.54
Operating CF/Net income
(1.13) 0.55 1.52 0.98 3.22 2.82 0.59 (0.44) (1.57) 12.94
Capex/Depreciation
(0.52) (0.54) (0.49) (0.52) (0.59) (0.84) (0.64) (0.24) (0.41) (0.97)
Interest Coverage
4.07 14.47 14.43 10.66 8.50 10.57 12.00 9.83 (4.70) 3.03
ROE
11.02% 27.07% 30.39% 28.32% 27.89% 33.19% 40.86% 47.39% (34.29%) 3.24%
ROA
3.03% 7.73% 8.02% 6.46% 6.06% 8.25% 10.57% 9.05% (6.43%) 0.74%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
8.78% 22.83% 23.49% 22.71% 19.31% 20.38% 23.91% 28.77% (22.30%) 2.78%
Average Days of Receivables
28.39 29.62 33.25 26.28 28.61 31.42 30.49 25.70 15.99 20.79
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
6.62% 6.75% 7.23% 7.23% 7.45% 7.62% 7.70% 7.06% 8.02% 7.83%
Intangible Assets out of Total Assets
0.14 0.12 0.10 0.11 0.10 0.10 0.03 0.03 0.03 0.10
Share Based Compensation of Revenue
0.10% 0.29% 0.34% 0.32% 0.26% 0.29% 0.23% 0.14% 0.23% 0.15%
Graham Net Nets
0.10 0.10 0.09 0.04 0.03 0.04 0.14 0.13 0.09 0.06
Graham Number
121.83 189.75 175.69 125.04 107.32 94.74 90.18 80.13 0.00 24.85
Earnings Yield
4.93% 7.02% 5.05% 4.25% 3.54% 5.28% 8.45% 9.09% (11.56%) 1.72%
Free Cash Flow Yield
(6.94%) 3.26% 7.36% 3.70% 11.11% 14.54% 4.47% (4.85%) 16.44% 16.74%
Revenue per Share
860.34 708.19 590.50 553.18 480.47 329.20 270.56 309.67 355.05 320.97
Operating CF per Share
(10.13) 11.22 28.80 13.37 36.66 32.17 6.98 (5.15) 14.36 12.15
Capex per Share
(1.91) (1.74) (1.46) (1.57) (1.33) (1.25) (0.92) (0.49) (1.54) (3.18)
Free Cash Flow per Share
(12.05) 9.48 27.35 11.80 35.33 30.92 6.06 (5.64) 12.82 8.97
Cash per Share
156.36 156.57 157.83 129.84 132.18 102.19 70.71 73.89 104.98 82.62
Shareholders Equity per Share
77.06 78.33 73.05 51.28 45.50 35.53 31.51 27.00 23.88 29.77
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
77.06 78.33 73.05 51.28 45.50 35.53 31.51 27.00 23.88 29.77
Free Cash Flow
(636.00) 544.00 1,578.00 682.00 2,042.00 1,824.00 377.00 (344.00) 718.00 497.00
Working Capital
5,072.00 4,877.00 4,374.00 3,229.00 3,017.00 2,911.00 2,698.00 2,216.00 1,954.00 1,418.00
Capital Expenditures
(101.00) (100.00) (84.00) (91.00) (77.00) (74.00) (57.00) (30.00) (86.00) (176.00)
Net Current Asset Value
949.00 1,639.00 1,865.00 734.00 485.00 440.00 1,140.00 955.00 377.00 188.00
EV/EBIT
6.25 6.36 9.37 11.38 12.90 8.25 5.29 3.57 0.00 0.12
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Price to Operating Income
11.73 9.79 13.63 15.71 18.02 11.64 8.08 6.27 0.00 9.70
Other line items
Depreciation/Fixed assets
0.65 0.65 0.63 0.68 0.33 0.23 0.23 0.53 0.61 0.40
Cash ROIC
(3.91%) 3.28% 10.05% 5.30% 16.13% 17.41% 4.82% (4.52%) 7.65% 6.31%
Accounts Receivable Turnover
13.30 12.70 12.61 14.28 14.43 12.62 12.30 17.16 21.11 21.91
Accounts Payable Turnover
32.58 26.66 26.78 31.40 31.97 27.68 31.18 41.01 46.78 40.85
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
10.10 14.11 15.94 11.94 12.97 14.79 13.18 9.18 7.61 9.21
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
3,416.00 3,201.50 2,703.00 2,239.50 1,924.50 1,539.00 1,368.00 1,100.50 942.00 811.50
Average Payables
1,212.00 1,291.50 1,070.50 865.50 741.50 571.50 446.00 378.00 375.50 373.50
Average Assets
15,597.00 15,261.00 13,603.00 12,261.50 10,870.50 8,159.50 6,970.50 7,812.50 7,960.00 7,012.50
Average Common Equity
4,282.50 4,355.50 3,589.50 2,797.00 2,363.00 2,028.00 1,803.50 1,492.00 1,493.00 1,603.00

Fold the line items

Columns are period end dates